Thomas McCoy Roberts, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antigens, Polyomavirus Transforming | 27 | 2016 | 306 | 3.660 |
Why?
|
| Helminth Proteins | 12 | 2012 | 177 | 3.170 |
Why?
|
| Phosphatidylinositol 3-Kinases | 39 | 2020 | 2629 | 2.870 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 17 | 2021 | 788 | 2.730 |
Why?
|
| Ascaris | 7 | 2012 | 25 | 2.400 |
Why?
|
| Polyomavirus | 12 | 2016 | 245 | 2.160 |
Why?
|
| Sperm Motility | 7 | 2012 | 256 | 2.130 |
Why?
|
| Spermatozoa | 9 | 2012 | 626 | 1.930 |
Why?
|
| Class Ia Phosphatidylinositol 3-Kinase | 4 | 2020 | 58 | 1.740 |
Why?
|
| PTEN Phosphohydrolase | 13 | 2020 | 1100 | 1.600 |
Why?
|
| Cytoskeleton | 11 | 2012 | 1254 | 1.430 |
Why?
|
| Ascaris suum | 5 | 2008 | 9 | 1.360 |
Why?
|
| Protein Phosphatase 2 | 9 | 2016 | 229 | 1.220 |
Why?
|
| Cell Transformation, Neoplastic | 22 | 2017 | 3067 | 1.170 |
Why?
|
| Antigens, Viral, Tumor | 7 | 2014 | 152 | 1.100 |
Why?
|
| Signal Transduction | 59 | 2019 | 23890 | 1.100 |
Why?
|
| Adaptor Proteins, Signal Transducing | 10 | 2018 | 2552 | 1.060 |
Why?
|
| Cell Transformation, Viral | 11 | 2016 | 682 | 1.050 |
Why?
|
| Protein-Serine-Threonine Kinases | 20 | 2018 | 3992 | 0.990 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 2 | 2012 | 76 | 0.940 |
Why?
|
| Proto-Oncogene Proteins | 31 | 2014 | 4655 | 0.940 |
Why?
|
| Pseudopodia | 5 | 2009 | 207 | 0.890 |
Why?
|
| Proto-Oncogene Proteins c-raf | 16 | 2010 | 216 | 0.760 |
Why?
|
| Frameshift Mutation | 1 | 2020 | 408 | 0.750 |
Why?
|
| Simian virus 40 | 11 | 2014 | 366 | 0.740 |
Why?
|
| Protein-Tyrosine Kinases | 30 | 2008 | 2423 | 0.730 |
Why?
|
| 3T3 Cells | 17 | 2014 | 1163 | 0.720 |
Why?
|
| Phosphorylation | 45 | 2019 | 8870 | 0.690 |
Why?
|
| Phosphoproteins | 12 | 2016 | 2649 | 0.630 |
Why?
|
| rac1 GTP-Binding Protein | 2 | 2016 | 248 | 0.620 |
Why?
|
| Androgen Receptor Antagonists | 2 | 2013 | 110 | 0.620 |
Why?
|
| Membrane Microdomains | 1 | 2016 | 224 | 0.610 |
Why?
|
| Animals | 128 | 2021 | 168394 | 0.600 |
Why?
|
| Isoenzymes | 6 | 2014 | 1853 | 0.590 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 4 | 2017 | 1559 | 0.580 |
Why?
|
| Proto-Oncogene Proteins c-akt | 15 | 2017 | 2517 | 0.580 |
Why?
|
| Aminopyridines | 5 | 2019 | 350 | 0.550 |
Why?
|
| Morpholines | 5 | 2019 | 529 | 0.550 |
Why?
|
| Protein Kinases | 11 | 2009 | 1700 | 0.540 |
Why?
|
| Cell Movement | 8 | 2005 | 5675 | 0.530 |
Why?
|
| Tumor Suppressor Protein p53 | 9 | 2014 | 2878 | 0.510 |
Why?
|
| Phosphoprotein Phosphatases | 4 | 2006 | 366 | 0.510 |
Why?
|
| Mice | 69 | 2021 | 79101 | 0.500 |
Why?
|
| src Homology Domains | 5 | 2003 | 359 | 0.490 |
Why?
|
| Neoplasms | 14 | 2018 | 18379 | 0.480 |
Why?
|
| Gene Targeting | 1 | 2016 | 948 | 0.480 |
Why?
|
| Tyrosine | 12 | 2003 | 1511 | 0.470 |
Why?
|
| Zebrafish | 7 | 2010 | 2894 | 0.470 |
Why?
|
| Eukaryotic Initiation Factor-4E | 1 | 2011 | 124 | 0.440 |
Why?
|
| Prostatic Neoplasms | 6 | 2014 | 10061 | 0.430 |
Why?
|
| Neuropeptides | 1 | 2016 | 1013 | 0.420 |
Why?
|
| Oncogenes | 8 | 2000 | 1120 | 0.410 |
Why?
|
| Platelet-Derived Growth Factor | 11 | 2001 | 636 | 0.400 |
Why?
|
| Enzyme Activation | 17 | 2019 | 3982 | 0.400 |
Why?
|
| Phosphatidylinositol 3-Kinase | 3 | 2019 | 126 | 0.400 |
Why?
|
| Amino Acid Sequence | 31 | 2016 | 14610 | 0.400 |
Why?
|
| Cell Survival | 7 | 2015 | 6329 | 0.390 |
Why?
|
| Retroviridae | 7 | 2003 | 1006 | 0.390 |
Why?
|
| Cell Membrane | 4 | 2016 | 3944 | 0.380 |
Why?
|
| Protein Kinase Inhibitors | 10 | 2019 | 5097 | 0.380 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 4 | 2012 | 557 | 0.380 |
Why?
|
| Protein Tyrosine Phosphatases | 3 | 2003 | 499 | 0.370 |
Why?
|
| Molecular Sequence Data | 32 | 2007 | 19491 | 0.370 |
Why?
|
| Cell Line | 39 | 2021 | 17037 | 0.350 |
Why?
|
| Cell Line, Tumor | 18 | 2020 | 16683 | 0.350 |
Why?
|
| Zebrafish Proteins | 3 | 2010 | 1054 | 0.350 |
Why?
|
| beta-Galactosidase | 1 | 2008 | 638 | 0.340 |
Why?
|
| Virulence Factors | 1 | 2011 | 502 | 0.340 |
Why?
|
| Nuclear Proteins | 5 | 2017 | 6005 | 0.340 |
Why?
|
| Mutagenesis, Insertional | 2 | 2008 | 665 | 0.340 |
Why?
|
| Breast Neoplasms | 10 | 2020 | 18886 | 0.330 |
Why?
|
| Aging | 2 | 2021 | 8010 | 0.330 |
Why?
|
| Mammary Glands, Human | 2 | 2005 | 231 | 0.330 |
Why?
|
| Gene Amplification | 1 | 2011 | 1097 | 0.330 |
Why?
|
| Sequence Homology, Amino Acid | 11 | 2007 | 3036 | 0.330 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2011 | 1008 | 0.320 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 3744 | 0.320 |
Why?
|
| Precipitin Tests | 11 | 2004 | 924 | 0.320 |
Why?
|
| Spermatids | 1 | 2005 | 37 | 0.310 |
Why?
|
| Nematoda | 1 | 2005 | 27 | 0.310 |
Why?
|
| Proto-Oncogenes | 6 | 1994 | 350 | 0.300 |
Why?
|
| Drug Delivery Systems | 3 | 2016 | 2256 | 0.300 |
Why?
|
| Phosphotransferases | 6 | 1992 | 288 | 0.300 |
Why?
|
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 7 | 2000 | 98 | 0.300 |
Why?
|
| Hematopoiesis | 4 | 2019 | 1943 | 0.300 |
Why?
|
| Cell Differentiation | 10 | 2016 | 11662 | 0.290 |
Why?
|
| Molecular Targeted Therapy | 4 | 2016 | 2754 | 0.280 |
Why?
|
| Spermatogenesis | 1 | 2005 | 254 | 0.280 |
Why?
|
| Mutation | 20 | 2021 | 27841 | 0.280 |
Why?
|
| Tyrosine 3-Monooxygenase | 2 | 1994 | 378 | 0.270 |
Why?
|
| Transcription Factors | 14 | 2016 | 11816 | 0.270 |
Why?
|
| TOR Serine-Threonine Kinases | 5 | 2018 | 2068 | 0.270 |
Why?
|
| Phthalazines | 4 | 2018 | 279 | 0.260 |
Why?
|
| Retinoblastoma Protein | 3 | 2007 | 746 | 0.260 |
Why?
|
| Fibroblasts | 11 | 2016 | 4327 | 0.260 |
Why?
|
| Molecular Weight | 11 | 2005 | 2566 | 0.260 |
Why?
|
| Schwann Cells | 2 | 2001 | 206 | 0.250 |
Why?
|
| Drug Resistance, Neoplasm | 9 | 2019 | 4993 | 0.250 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 6 | 1997 | 513 | 0.250 |
Why?
|
| Cell Division | 11 | 2004 | 4981 | 0.250 |
Why?
|
| Oncogene Proteins | 2 | 2006 | 745 | 0.250 |
Why?
|
| Carrier Proteins | 5 | 2018 | 5285 | 0.250 |
Why?
|
| ras Proteins | 4 | 2014 | 1142 | 0.240 |
Why?
|
| Embryonic Structures | 1 | 2001 | 8 | 0.240 |
Why?
|
| Lysine | 5 | 2016 | 1025 | 0.240 |
Why?
|
| Notochord | 1 | 2001 | 39 | 0.240 |
Why?
|
| Multiprotein Complexes | 3 | 2018 | 1174 | 0.240 |
Why?
|
| Phenylthiohydantoin | 2 | 2013 | 175 | 0.240 |
Why?
|
| Cyclins | 1 | 2004 | 657 | 0.240 |
Why?
|
| Protein Isoforms | 4 | 2020 | 1722 | 0.230 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2006 | 1376 | 0.230 |
Why?
|
| Membrane Proteins | 5 | 2018 | 8055 | 0.230 |
Why?
|
| ADP-Ribosylation Factor 1 | 2 | 2016 | 47 | 0.230 |
Why?
|
| Cyclin D1 | 2 | 2001 | 517 | 0.230 |
Why?
|
| Apoptosis | 7 | 2016 | 10270 | 0.230 |
Why?
|
| Histones | 5 | 2016 | 2555 | 0.220 |
Why?
|
| Cell Cycle | 9 | 2019 | 3101 | 0.220 |
Why?
|
| Enzyme Inhibitors | 8 | 2019 | 3995 | 0.220 |
Why?
|
| Receptor, erbB-2 | 7 | 2019 | 2220 | 0.220 |
Why?
|
| Protein Biosynthesis | 4 | 2018 | 2230 | 0.220 |
Why?
|
| DNA, Complementary | 7 | 2018 | 2155 | 0.220 |
Why?
|
| Genes, Switch | 1 | 2000 | 49 | 0.220 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 7 | 2014 | 1544 | 0.220 |
Why?
|
| Embryo, Nonmammalian | 3 | 2008 | 980 | 0.220 |
Why?
|
| Antineoplastic Agents | 7 | 2019 | 13647 | 0.210 |
Why?
|
| Genes, Tumor Suppressor | 3 | 2017 | 1115 | 0.210 |
Why?
|
| MAP Kinase Kinase Kinases | 2 | 2012 | 285 | 0.210 |
Why?
|
| Ovarian Neoplasms | 4 | 2018 | 4529 | 0.210 |
Why?
|
| Endoplasmic Reticulum | 1 | 2006 | 1157 | 0.210 |
Why?
|
| Oncogene Proteins, Viral | 2 | 2014 | 407 | 0.210 |
Why?
|
| Binding Sites | 13 | 2005 | 6468 | 0.210 |
Why?
|
| Humans | 88 | 2020 | 655361 | 0.200 |
Why?
|
| cdc25 Phosphatases | 1 | 1999 | 70 | 0.200 |
Why?
|
| Receptor Cross-Talk | 1 | 1999 | 130 | 0.200 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2006 | 1466 | 0.200 |
Why?
|
| Carcinoma | 1 | 2011 | 2326 | 0.200 |
Why?
|
| Protein Binding | 13 | 2008 | 9915 | 0.200 |
Why?
|
| Phenylenediamines | 1 | 2019 | 94 | 0.200 |
Why?
|
| Genes, ras | 5 | 2014 | 728 | 0.200 |
Why?
|
| Myristic Acid | 4 | 2005 | 53 | 0.200 |
Why?
|
| Mutagenesis, Site-Directed | 6 | 2014 | 1866 | 0.190 |
Why?
|
| GTPase-Activating Proteins | 1 | 2001 | 421 | 0.190 |
Why?
|
| Cells, Cultured | 16 | 2016 | 20648 | 0.190 |
Why?
|
| Recombinant Fusion Proteins | 10 | 2010 | 3964 | 0.190 |
Why?
|
| Eukaryotic Initiation Factors | 2 | 2016 | 90 | 0.180 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2010 | 1384 | 0.180 |
Why?
|
| Tumor Virus Infections | 2 | 2016 | 441 | 0.180 |
Why?
|
| RNA-Binding Proteins | 2 | 2018 | 1818 | 0.180 |
Why?
|
| Spodoptera | 5 | 1999 | 163 | 0.180 |
Why?
|
| Epithelial Cells | 5 | 2017 | 3702 | 0.180 |
Why?
|
| Cyclin-Dependent Kinase 6 | 2 | 2017 | 277 | 0.180 |
Why?
|
| Actins | 5 | 2007 | 2233 | 0.180 |
Why?
|
| Protein Structure, Tertiary | 6 | 2012 | 4251 | 0.170 |
Why?
|
| Phosphotyrosine | 8 | 2009 | 460 | 0.170 |
Why?
|
| Proteins | 7 | 2018 | 6211 | 0.170 |
Why?
|
| Genes, src | 3 | 2008 | 61 | 0.170 |
Why?
|
| Quinolines | 2 | 2012 | 700 | 0.170 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 3 | 1996 | 395 | 0.170 |
Why?
|
| Adipocytes | 2 | 2006 | 1161 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-jun | 2 | 1995 | 308 | 0.170 |
Why?
|
| Oncogene Protein p21(ras) | 2 | 1994 | 98 | 0.170 |
Why?
|
| Substrate Specificity | 5 | 2016 | 1977 | 0.170 |
Why?
|
| Cyclin-Dependent Kinase 4 | 2 | 2017 | 443 | 0.160 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1998 | 1487 | 0.160 |
Why?
|
| Transfection | 15 | 2003 | 6405 | 0.160 |
Why?
|
| Oncogene Protein pp60(v-src) | 3 | 1992 | 80 | 0.160 |
Why?
|
| Peptide Mapping | 6 | 1995 | 288 | 0.160 |
Why?
|
| Ribosomal Proteins | 1 | 2018 | 369 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-fos | 3 | 1999 | 604 | 0.160 |
Why?
|
| Brain | 2 | 2021 | 23147 | 0.150 |
Why?
|
| Cell Proliferation | 9 | 2017 | 10869 | 0.150 |
Why?
|
|